Study Protocol
Published on 29 Jul 2025
Fruquintinib and sintilimab plus SOX as perioperative therapy for locally resectable advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, single-arm, phase II clinical trial
in Cancer Immunity and Immunotherapy
- 246 views